Screening by anti-endomysium antibodies for celiac disease in Tunisian children with type 1 diabetes mellitus

Gastroenterol Clin Biol. 2007 May;31(5):462-6. doi: 10.1016/s0399-8320(07)89413-9.

Abstract

Aim: Celiac disease (CD) and type 1 diabetes mellitus (DM1) can frequently coexist, presumably due to a common genetic predisposition. The present study was designed to evaluate the frequency of CD among Tunisian children with DM1.

Patients and methods: A total of 205 diabetic children (92 girls, 113 boys, age range 6 months-15 years, median 11 years) were screened for CD by determination of IgA anti-endomysium antibodies (EMA).

Results: EMA were positive in 17 out of 205 (8.3%) children with DM1. The median age of DM1 at onset was significantly lower in patients with EMA than those without EMA (P<10(-7)). In 13 of 17 EMA-positive patients, duodenal biopsy could be performed and a destructive type of CD was confirmed in 11 of them: 8 patients showed total villous atrophy, 3 patients showed a partial villous atrophy. The other two patients showed a normal histological picture with normal number of intraepithelial lymphocytes. Parents of the remaining EMA-positive children refused endoscopy. Thus the prevalence of biopsy-proven CD was 5.3% (11/205). It was 7.6% (7/92) in girls and 3.5% (4/113) in boys but the difference was not statistically significant. Seventy three percent of patients with CD were asymptomatic.

Conclusions: The prevalence of clinically unrecognized CD, found by EMA screening, is high in Tunisian children with DM1. We suggest that children with diabetes should be screened for CD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age of Onset
  • Atrophy
  • Autoantibodies / blood*
  • Biopsy
  • Celiac Disease / diagnosis*
  • Celiac Disease / pathology
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1 / complications*
  • Duodenum / pathology
  • Female
  • Fluorescein
  • Fluorescent Antibody Technique, Indirect
  • Fluorescent Dyes
  • Humans
  • Immunoglobulin A / blood
  • Infant
  • Intestinal Mucosa / pathology
  • Lymphocytes / pathology
  • Male
  • Mass Screening*
  • Muscle Fibers, Skeletal / immunology*
  • Prospective Studies
  • Tunisia

Substances

  • Autoantibodies
  • Fluorescent Dyes
  • Immunoglobulin A
  • Fluorescein